.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent oncological research highlights the pivotal role of CHD4 in tumor progression and its complex function within the nucleosome-remodeling and deacetylase (NuRD) complex. As a core ATP-dependent factor, CHD4 governs essential cellular processes like gene expression and DNA damage response. Interestingly, its function depends heavily on the specific tumor environment. While it often drives cancer development, it can also act as a tumor suppressor in certain transcriptional settings. Consequently, understanding these dual roles is vital for developing effective oncology treatments.
Furthermore, CHD4 significantly influences tumor growth by regulating key signaling pathways and maintaining the silencing of tumor suppressor genes. This protein also promotes metabolic adaptation, which helps cancer cells survive under metabolic stress. Beyond its role in growth, CHD4 is a critical player in the DNA damage response (DDR). It facilitates chromatin remodeling at damage sites and assists in cell cycle recovery. Moreover, it guides the selection of specific repair pathways, ensuring genomic stability even during therapeutic stress.
However, the most challenging aspect involves its contribution to treatment resistance. CHD4 helps tumor cells evade the effects of chemotherapy and radiation through several distinct mechanisms. For instance, it regulates drug efflux and stabilizes replication forks during DNA synthesis. Additionally, it alters the tumor immune microenvironment to protect malignant cells from immune detection. Because various non-coding RNAs modulate its stability and localization, CHD4 serves as a central hub for therapeutic evasion. Therefore, targeting this protein could potentially reverse resistance and improve clinical outcomes for cancer patients.
CHD4 is a chromatin-remodeling factor that regulates gene expression and DNA repair. It can either promote tumor growth or suppress it, depending on the specific cellular and transcriptional context.
It promotes resistance by enhancing DNA repair efficiency, increasing drug efflux, and stabilizing replication forks, which allows cancer cells to survive intensive therapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A review of CHD4's dual role in cancer, highlighting its impact on chromatin remodeling, DNA repair, and its contribution to treatment resistance....
6 months ago
Recent epidemiological data reveals a dramatic surge in summer heat mortality driven by human-induced climate warming. This analysis explores the pathophysiological impacts on cardiac and renal systems, diagnostic dilemmas in death certification, and essential emergency cooling protocols for acute clinical care.
Today
Odisha has established India's first state-level clinical protocol specifically tailored for pregnant women with sickle cell disease. Developed with NHM and UNICEF, the framework provides structured antenatal screening, crisis mitigation, standardized referral pathways, and specialized interdisciplinary care.
Today
India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today
A randomized controlled trial demonstrates that an eight-week dual-task training intervention significantly improves static and dynamic postural control over standard balance exercises in individuals with chronic ankle instability, addressing critical neurocognitive deficits during athletic and daily activities.
Today
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
